Status: Recruiting
Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients
The study is a single center, open, prospective, self controlled clinical study. The patients with diabetes who are to be enrolled in peritoneal dialysis are to observe the changes of glycosylated hemoglobin relative to the baseline 90 days after using amino acid (15) peritoneal dialysis solution.
Participants needed: 70
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: The People's Hospital of GaozhouUpdated: Jul 22, 2025Locations: 1
Eligibility criteria
Type I or II diabetes patients aged 18 to 75 years (including 18 and 75 years),... [+9]
Peritonitis has occurred within the past 3 months; [+10]